Skip to content

EC-MOTION : ExtraCorporeal Membrane Oxygenation and Therapeutic Drug Monitoring of Drugs of infectION

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02917486
Acronym
EC-MOTION
Enrollment
44
Registered
2016-09-28
Start date
2016-01-01
Completion date
2019-07-01
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

ExtraCorporeal Membrane Oxygenation, patient in intensive care, pharmacokinetic modeling

Brief summary

The objective of the study is to investigate the exposure difference between antibiotic studied patients in intensive care with Extracorporeal Membrane Oxygenation and patients without Extracorporeal Membrane Oxygenation. The exhibition is evaluated by population pharmacokinetic modeling.

Interventions

OTHERblood sample

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years * Hospitalisation in intensive care * Treatment with ECMO or without ECMO * Introducing sepsis treated with an anti-infective molecule studied (piperacillin) for less than 48 hours * With an arterial catheter * Patient Information or their next of kin according to the patients status.

Exclusion criteria

* Pregnancy * Major person under legal protection (backup justice, trusteeship, quardianship), person deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Measure exposure to piperacillinDay 1evaluated by population pharmacokinetic modeling and is defined by the time during which the antibiotic concentration is greater than 4 times the critical concentration of the germ to treat

Countries

France

Contacts

PRINCIPAL_INVESTIGATORPierre Fillatre

Rennes University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026